Adaptive Biotechnologies
1551 Eastlake Ave E
Suite 200
Seattle
Washington
98102
United States
159 articles about Adaptive Biotechnologies
-
Adaptive Biotech Announces A Collaboration With Janssen Biotech To Use The clonoSEQ? Assay To Measure Minimal Residual Disease In Ongoing And Future DARZALEX? Multiple Myeloma Trials
6/22/2017
-
Adaptive Biotech Announces A Collaboration With Janssen Biotech To Use The Clonoseq Assay To Measure Minimal Residual Disease In Ongoing And Future DARZALEX Multiple Myeloma Trials
6/21/2017
-
CSols, Inc Enhances And Extends GenoLogics Clarity LIMS For Adaptive Biotech
5/22/2017
-
Adaptive Biotech Publishes Ground-Breaking Proof-Of-Principle Experiment In Nature Genetics
4/5/2017
-
Adaptive Biotech Announces A Collaboration With Amgen To Advance Development Of Clonoseq Assay In Acute Lymphoblastic Leukemia
1/6/2017
-
Adaptive Biotech Announces The Inclusion Of NGS-Based MRD Assessment In The NCCN Clinical Practice Guidelines For Multiple Myeloma
10/28/2016
-
Heat Biologics And Adaptive Biotech To Discover Potential Clinical Biomarkers To Advance Novel Immunotherapies
10/11/2016
-
Adaptive Biotech Release: World’s Leading Experts To Discuss The Advances Of Immune Profiling In Health And Disease During Unparalleled Conference
10/4/2016
-
Adaptive Biotech Provides Open-Access To The Deepest Immunosequencing Dataset Of Unique B-Cell Receptors (BCRs) For Immunology Research
8/23/2016
-
Adaptive Biotech And Collaborators To Present Data Demonstrating High-Throughput Sequencing For Minimal Residual Disease (MRD) Is More Sensitive Than Flow Cytometry And Can Be Used As A Determinant Of Early Response To Therapy
6/10/2016
-
ASCO2016: Adaptive Biotech And Collaborators To Present Seven Studies Demonstrating The Use Of Immunosequencing To Identify Prognostic Biomarkers And Potential Biomarkers Of Response At The 2016 American Society Of Clinical Oncology Annual Meeting
6/6/2016
-
Adaptive Biotech To Present 2 Studies Demonstrating Utility Of Immunosequencing To Propel Diagnostic Development And Therapeutic Discovery At The 2016 American Association Of Immunologists Annual Meeting
5/16/2016
-
Seattle’s Adaptive Biotech Looks to Hire 50 Employees in 2016 to Buttress Fast Growth
4/26/2016
-
Adaptive Biotech And Collaborators To Present 10 Studies Demonstrating The Utility Of Immunosequencing In Both Tissue And Blood Samples At 2016 AACR Annual Meeting
4/18/2016
-
Adaptive Biotech Welcomes Charles Sang As Senior Vice President Of Diagnostics
4/11/2016
-
Seattle's Adaptive Biotech to Base New Business in San Diego with Ex-Johnson & Johnson Exec in Charge
3/21/2016
-
Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotech As President Of Adaptive Therapeutics
3/15/2016
-
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
2/18/2016
-
Pfizer Enters Into Translational Research Collaboration With Adaptive Biotech To Help Advance Novel Immuno-Oncology Solutions
1/8/2016
-
Adaptive Biotech To Present At The 34th Annual J.P. Morgan Healthcare Conference
1/6/2016